Application of Outer Membrane Vesicle of Neisseria meningitidis Serogroup B as a New Adjuvant to Induce Strongly Th1-Oriented Responses Against HIV-1

Aghasadeghi, Mohammad Reza; Salmani, Ali Sharifat; Sadat, Seyed Mehdi; Javadi, Foozieh; Memarnejadian, Arash; Vahabpour, Rouhoullah; Zabihollahi, Rezvan; Moshiri, Arfa; Siadat, Seyed Davar
December 2011
Current HIV Research;Dec2011, Vol. 9 Issue 8, p630
Academic Journal
Despite the worldwide efforts made in the field of HIV vaccine development, an efficient AIDS vaccine strategy is still vague. Virus-like particles (VLPs) are one of the introduced aspects for HIV vaccine development since the non-replicative nature of HIV VLPs, resulting from the lack of viral genomic RNA, makes them suitable for broad applications. We have previously designed and introduced non-infectious VLPs (mzNL4-3) by introduction of a deletion mutation in the reverse transcriptase and integrase coding regions of HV-1. There are evidences suggesting that an effective cellular immune response against HIV-1 is able to control and suppress viremia during primary and chronic HIV infections. In the present study we have evaluated the potency of mzNL4-3 VLPs mixed with Neisseria meningitidis serogroup B outer-membrane vesicle (OMV), which is among the microbial components with proved adjuvant properties, to induce humoral and cellular responses against HIV-1. Analysis of anti-HIV-1 responses elicited in immunized BALB/c mice following different immunization regimens indicated OMV+VLP as an immunopotent combination which significantly induced anti-HIV-1 IgG with IgG2a dominancy. Results of cytokine and ELISpot assays also showed the capability of VLP+OMV immunogen for effective induction of IFN-γ and IL4 secreting cells and further suggested the promotion of Th1-oriented response that was evidenced with the increased IFN-γ/IL4 secretion ratio. According to our study, HIV-1 VLPs combined with N. meningitidis B OMVs seem to be a promising approach in vaccine development against HIV-1.


Related Articles

  • Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules. Johnson, Steven; Tan, Lionel; van der Veen, Stijn; Caesar, Joseph; De Jorge, Elena Goicoechea; Harding, Rachel J.; Xilian Bai; Exley, Rachel M.; Ward, Philip N.; Ruivo, Nicola; Trivedi, Kaushali; Cumber, Elspeth; Jones, Rhian; Newham, Luke; Staunton, David; Ufret-Vincenty, Rafael; Borrow, Ray; Pickering, Matthew C.; Lea, Susan M.; Tang, Christoph M. // PLoS Pathogens;Oct2012, Vol. 8 Issue 10, Special section p1 

    Neisseria meningitis remains a leading cause of sepsis and meningitis, and vaccines are required to prevent infections by this important human pathogen. Factor H binding protein (fHbp) is a key antigen that elicits protective immunity against the meningococcus and recruits the host complement...

  • Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL. Gianotti, Nicola; Galli, Laura; Racca, Sara; Salpietro, Stefania; Cossarini, Francesca; Spagnuolo, Vincenzo; Barda, Beatrice; Canducci, Filippo; Clementi, Massimo; Lazzarin, Adriano; Castagna, Antonella // Journal of Antimicrobial Chemotherapy (JAC);Jan2012, Vol. 67 Issue 1, p213 

    Objectives It is currently debated whether patients with residual viraemia are at higher risk of virological failure than those attaining <1 HIV RNA copy/mL. We therefore investigated the effect of residual viraemia on virological rebound. Methods We used a prospective, non-interventional,...

  • Hyperthermia Stimulates HIV-1 Replication. Roesch, Ferdinand; Meziane, Oussama; Kula, Anna; Nisole, Sébastien; Porrot, Franc¸oise; Anderson, Ian; Mammano, Fabrizio; Fassati, Ariberto; Marcello, Alessandro; Benkirane, Monsef; Schwartz, Olivier // PLoS Pathogens;Jul2012, Vol. 8 Issue 7, Special section p1 

    HIV-infected individuals may experience fever episodes. Fever is an elevation of the body temperature accompanied by inflammation. It is usually beneficial for the host through enhancement of immunological defenses. In cultures, transient non-physiological heat shock (42-45°C) and Heat Shock...

  • Global Dynamics of a Delayed HIV-1 Infection Model with CTL Immune Response. Yunfei Li; Rui Xu; Zhe Li; Shuxue Mao // Discrete Dynamics in Nature & Society;2011, Special section p1 

    A delayed HIV-1 infection model with CTL immune response is investigated. By using suitable Lyapunov functionals, it is proved that the infection-free equilibrium is globally asymptotically stable if the basic reproduction ratio for viral infection is less than or equal to unity; if the basic...

  • Induction of Strong Anti-HIV Cellular Immunity by a Combination of Clostridium Perfringens Expressing HIV Gag and Virus Like Particles. Pegu, Poonam; Helmus, Ruth; Gupta, Phalguni; Tarwater, Patrick; Caruso, Lori; Chengli Shen; Ross, Ted; Yue Chen // Current HIV Research;Dec2011, Vol. 9 Issue 8, p613 

    The lower gastrointestinal tract is a major mucosal site of HIV entry and initial infection. Thus, the induction of strong cellular immune responses at this mucosal site will be an important feature of an effective HIV vaccine. We have used a novel prime-boost vaccination approach to induce...

  • A dendrite in every pie. Wonderlich, Elizabeth R.; Barratt-Boyes, Simon M. // Virulence;11/15/2012, Vol. 3 Issue 7, p647 

    Dendritic cells (DC) are a heterogeneous population of innate immune cells that are fundamental to initiating responses against invading pathogens and regulating immune responses. Myeloid DC (mDC) act as a bridge between the innate and adaptive immune response during virus infections but their...

  • Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients. Yue, Ling; Pfafferott, Katja J.; Baalwa, Joshua; Conrod, Karen; Dong, Catherine C.; Chui, Cecilia; Rong, Rong; Claiborne, Daniel T.; Prince, Jessica L.; Tang, Jianming; Ribeiro, Ruy M.; Cormier, Emmanuel; Hahn, Beatrice H.; Perelson, Alan S.; Shaw, George M.; Karita, Etienne; Gilmour, Jill; Goepfert, Paul; Derdeyn, Cynthia A.; Allen, Susan A. // PLoS Pathogens;Jan2015, Vol. 11 Issue 1, p1 

    Control of virus replication in HIV-1 infection is critical to delaying disease progression. While cellular immune responses are a key determinant of control, relatively little is known about the contribution of the infecting virus to this process. To gain insight into this interplay between...

  • HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial. Bart, Pierre-Alexandre; Yunda Huang; Karuna, Shelly T.; Chappuis, Samuel; Gaillard, Julien; Kochar, Nidhi; Xiaoying Shen; Allen, Mary A.; Song Ding; Hural, John; Hua-Xin Liao; Haynes, Barton F.; Graham, Barney S.; Gilbert, Peter B.; McElrath, M. Juliana; Monteiori, David C.; Tomaras, Georgia D.; Pantaleo, Giuseppe; Frahm, Nicole; Huang, Yunda // Journal of Clinical Investigation;Nov2014, Vol. 124 Issue 11, p4843 

    BACKGROUND. Vector prime-boost immunization strategies induce strong cellular and humoral immune responses. We examined the priming dose and administration order of heterologous vectors in HIV Vaccine Trials Network 078 (HVTN 078), a randomized, double-blind phase Ib clinical trial to evaluate...

  • Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption? Krastinova, Evguenia; Seng, Remonie; Lechenadec, Jerome; Panjo, Henri; Essat, Asma; Makhloufi, Djamila; Obadia, Martine; Bernard, Louis; Goujard, Cecile; Meyer, Laurence // BMC Infectious Diseases;2015, Vol. 15 Issue 1, p1 

    Background: We explored the impact of transient cART started during the primary HIV-infection (PHI) on the long-term immunologic and virologic response on cART resumption, by comparison with treatment initiation during the chronic phase of HIV infection (CHI). Methods: We analyzed data on 1450...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics